
### [MONDO:0020178](http://purl.obolibrary.org/obo/MONDO_0020178)
**Label:** palpebral lentiginosis

**Subclasses:** [MONDO:0015285](http://purl.obolibrary.org/obo/MONDO_0015285) (Carney complex), [MONDO:0007893](http://purl.obolibrary.org/obo/MONDO_0007893) (Noonan syndrome with multiple lentigines), [MONDO:0008280](http://purl.obolibrary.org/obo/MONDO_0008280) (Peutz-Jeghers syndrome), 

**Corr. equiv. classes:** [OMIM:175200](http://purl.obolibrary.org/obo/OMIM_175200), [Orphanet:2869](http://www.orpha.net/ORDO/Orphanet_2869), [Orphanet:500](http://www.orpha.net/ORDO/Orphanet_500), [Orphanet:1359](http://www.orpha.net/ORDO/Orphanet_1359), [OMIM:151100](http://purl.obolibrary.org/obo/OMIM_151100), 

**Class expressions from DL-Learner:**

- [HP:0100619](http://purl.obolibrary.org/obo/HP_0100619) (Sertoli cell neoplasm) 70.00%
- [HP:0100013](http://purl.obolibrary.org/obo/HP_0100013) (Neoplasm of the breast) and [HP:0100619](http://purl.obolibrary.org/obo/HP_0100619) (Sertoli cell neoplasm) 70.00%
- [HP:0031093](http://purl.obolibrary.org/obo/HP_0031093) (Abnormal breast morphology) and [HP:0100619](http://purl.obolibrary.org/obo/HP_0100619) (Sertoli cell neoplasm) 70.00%
- [HP:0031065](http://purl.obolibrary.org/obo/HP_0031065) (Abnormal ovarian morphology) and [HP:0100619](http://purl.obolibrary.org/obo/HP_0100619) (Sertoli cell neoplasm) 70.00%
- [HP:0025033](http://purl.obolibrary.org/obo/HP_0025033) (Abnormality of digestive system morphology) and [HP:0100619](http://purl.obolibrary.org/obo/HP_0100619) (Sertoli cell neoplasm) 70.00%
- [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) and [HP:0100619](http://purl.obolibrary.org/obo/HP_0100619) (Sertoli cell neoplasm) 70.00%
- [HP:0012733](http://purl.obolibrary.org/obo/HP_0012733) (Macule) and [HP:0100619](http://purl.obolibrary.org/obo/HP_0100619) (Sertoli cell neoplasm) 70.00%
- [HP:0012718](http://purl.obolibrary.org/obo/HP_0012718) (Morphological abnormality of the gastrointestinal tract) and [HP:0100619](http://purl.obolibrary.org/obo/HP_0100619) (Sertoli cell neoplasm) 70.00%
- [HP:0011842](http://purl.obolibrary.org/obo/HP_0011842) (Abnormality of skeletal morphology) and [HP:0100619](http://purl.obolibrary.org/obo/HP_0100619) (Sertoli cell neoplasm) 70.00%
- [HP:0011792](http://purl.obolibrary.org/obo/HP_0011792) (Neoplasm by histology) and [HP:0100619](http://purl.obolibrary.org/obo/HP_0100619) (Sertoli cell neoplasm) 70.00%
- [HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion) and [HP:0100619](http://purl.obolibrary.org/obo/HP_0100619) (Sertoli cell neoplasm) 70.00%
- [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) and [HP:0100619](http://purl.obolibrary.org/obo/HP_0100619) (Sertoli cell neoplasm) 70.00%
- [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) and [HP:0100619](http://purl.obolibrary.org/obo/HP_0100619) (Sertoli cell neoplasm) 70.00%
- [HP:0011024](http://purl.obolibrary.org/obo/HP_0011024) (Abnormality of the gastrointestinal tract) and [HP:0100619](http://purl.obolibrary.org/obo/HP_0100619) (Sertoli cell neoplasm) 70.00%
- [HP:0010788](http://purl.obolibrary.org/obo/HP_0010788) (Testicular neoplasm) and [HP:0025033](http://purl.obolibrary.org/obo/HP_0025033) (Abnormality of digestive system morphology) 70.00%


